Calorimetric investigation of solvent-mediated transformation of sulfamerazine polymorphism

Journal of Pharmaceutical Sciences

Volumn 99, Issue 1, 2010, Pages 76-81

  Kawakami, Kohsaku ^a   Asami, Yasuo ^b   Takenoshita, Itsuro ^b  

^a NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

^b TA INSTRUMENTS   (United States)

Author keywords

Differential scanning calorimetry; Microcalorimetry; Polymorphism; Solvent mediated transformation; Transition temperature

Indexed keywords

SULFAMERAZINE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG TRANSFORMATION; ENTHALPY; MICROCALORIMETRY; THERMAL ANALYSIS; TRANSITION TEMPERATURE;

EID: 73949094322     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21837     Document Type: Article

References (23)

1. Brittain HG. 1999. Polymorphism in pharmaceutical solids. New York: Marcel Dekker.
2. Matsuda Y, Tatsumi E. 1990. Physicochemical characterization of furosemide modifications. Int J Pharm 60:11-26.
3. Gu CH, Young V, Jr., Grant DJW. 2001. Polymorph screening: Influence of solvents on the rate of solvent-mediated polymorphic transformation. J Pharm Sci 90:1878-1890.
4. Morissette SL, Soukasene S, Levinson D, Cima MJ, Almarsson Ö. 2003. Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization. Proc Natl Acad Sci USA 100:2180-2184.
5. Miller JM, Collman BM, Greene LR, Grant DJW, Blackburn AC. 2005. Identifying the stable polymorph early in the drug discovery-development process. Pharm Dev Technol 10:291-297.
6. Burger A, Ramberger R. 1979. On the polymorphism of pharmaceuticals and other molecular crystals. I. Theory of thermodynamic rules. Mikrochimica Acta [Wien] II:259-271.
7. Burger A, Ramberger R. 1979. On the polymorphism of pharmaceuticals and other molecular crystals. II. Applicability of thermodynamic rules. Mikrochimica Acta [Wien] II:273-316.
8. Zhang GGZ, Gu C, Zell MT, Burkhardt RT, Munson EJ, Grant DJW. 2002. Crystallization and transitions of sulfamerazine polymorphs. J Pharm Sci 91: 1089-1100.
9. Kawakami K. 2007. Reversibility of enantiotropically-related polymorphic transformations from a practical viewpoint: Thermal analysis of kinetically reversible/irreversible polymorphic transformations. J Pharm Sci 96:982-989.
10. Kawakami K, Ida Y. 2005. Application of modulated-temperature DSC to the analysis of enantiotropically-related polymorphic transitions. Thermochim Acta 427:93-99.
11. Legas M, Lerk CF. 1981. The polymorphism of sulfathiazole. Int J Pharm 8:11-24.
12. Behme RJ, Brooke D. 1991. Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. J Pharm Sci 80:986-990.
13. He X, Griesser UJ, Stowell JG, Borchardt TB, Byrn SR. 2001. Conformational color polymorphism and control of crystallization of 5-methyl-2-[(4-methyl-2-nitrophenyl)amino]-3-thiophenecarbonitrile. J Pharm Sci 90:371-388.
14. Yu L. 1995. Inferring thermodynamic stability relationship of polymorphs from melting data. J Pharm Sci 84:966-974.
15. Phipps MA, Mackin LA. 2000. Application of isothermal microcalorimetry in solid state drug development. Pharm Sci Technol Today 3:9-17.
16. Kawakami K, Numa T, Ida Y. 2002. Assessment of amorphous content by microcalorimetry. J Pharm Sci 91:417-423.
17. Kawakami K, Ida Y. 2003. Direct observation of the enthalpy relaxation and the recovery processes of maltose-based amorphous formulation by isothermal microcalorimetry. Pharm Res 20:1430-1436.
18. Kawakami K, Pikal MJ. 2005. Calorimetric investigation of the structural relaxation of amorphous materials: Evaluating validity of the methodologies. J Pharm Sci 94:948-965.
19. Kawakami K, Miyoshi K, Ida Y. 2005. Impact of the amount of excess solids on apparent solubility. Pharm Res 22:1537-1543.
20. Kawakami K. 2007. Isothermal crystallization of Imwitor 742 from supercooled liquid state. Pharm Res 24:738-747.
21. Kissinger HE. 1957. Reaction kinetics in differential thermal analysis. Anal Chem 29:1702-1706.
22. Sheng J, Venkatesh GM, Duddu SP, Grant DJW. 1999. Dehydration behavior of eprosartan mesylate dihydate. J Pharm Sci 88:1021-1029.
23. Kawakami K, Ida Y, Yamaguchi T. 2005. Effect of salt type on hygroscopicity of a new cephalosporin S-3578. Pharm Res 22:1365-1373.